Literature DB >> 26975192

Cyclosporine A induced histological changes of Cathepsin L and CD2AP expression in renal glomeruli and tubules.

Keisuke Sugimoto1, Tomoki Miyazawa2, Takuji Enya2, Kouhei Miyazaki2, Mitsuru Okada2, Tsukasa Takemura2.   

Abstract

BACKGROUND: Cyclosporine A (CsA) is used globally as an immunosuppressant for the treatment of immune-mediated nephrotic syndrome (NS). However, its long-term use causes nephrotoxicity characterized by tubulointerstitial injury and glomerulosclerosis. The present study aimed to investigate the associations between histomorphological findings and immunohistological expression of Cathepsin L (CatL) and CD2-associated protein (CD2AP) in patients with NS mediated with CsA.
METHODS: A total of 18 patients with child-onset NS were divided into two groups after treatment with CsA for 2 years (group A; n = 10) and more than 4 years (group B; n = 8), respectively. Analyses of relationships between tubulointerstitial disorders and expression of CatL and CD2AP proteins were performed using immunohistochemistry of paired renal specimens.
RESULTS: Glomeruli with arteriole hyalinization were significantly increased in both groups depending on dosage periods, although degrees of tubule and interstitial injury did not differ between groups. CD2AP expression was significantly greater in podocytes (P = 0.046) and was significantly less in proximal tubule cells (P = 0.014) in patients of group B compared with those of group A. Moreover, CD2AP expression was significantly increased in lateral tubule cells in both groups (group A, P = 0.02; group B, P = 0.001), and CatL expression in glomeruli and tubule cells did not change with the duration of CsA treatment in either patient group.
CONCLUSIONS: CD2AP expression in renal tubules may histologically associate with tissue hypoxia and reflected recovery from CsA-mediated renal injury in patients, even with mild histological features of tubulointerstitial disorder.

Entities:  

Keywords:  CD2AP; Cathepsin L; Childhood; Cyclosporine A; Cyclosporine nephrotoxicity; Nephrotic syndrome

Mesh:

Substances:

Year:  2016        PMID: 26975192     DOI: 10.1007/s10157-016-1257-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  30 in total

1.  Glomerular basement membrane degradation by endogenous cysteine proteinases in isolated rat glomeruli.

Authors:  W H Baricos; S L Cortez; Q C Le; Y W Zhou; R M Dicarlo; S E O'Connor; S V Shah
Journal:  Kidney Int       Date:  1990-09       Impact factor: 10.612

Review 2.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

Review 3.  Calcineurin inhibitor nephrotoxicity.

Authors:  Maarten Naesens; Dirk R J Kuypers; Minnie Sarwal
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

Review 4.  Prevention of nephrotoxicity induced by cyclosporine-A: role of antioxidants.

Authors:  Sara Damiano; Roberto Ciarcia; Serena Montagnaro; Ugo Pagnini; Tiziana Garofano; Giovambattista Capasso; Salvatore Florio; Antonio Giordano
Journal:  J Cell Biochem       Date:  2015-03       Impact factor: 4.429

5.  Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes.

Authors:  Katsuhiko Asanuma; Isao Shirato; Kazumi Ishidoh; Eiki Kominami; Yasuhiko Tomino
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

6.  Effect of cyclosporin on kidney proteolytic enzymes in men and rats.

Authors:  C J Olbricht; M Steinker; W Auch-Schwelk; C Bossaller; J Haas; K M Koch
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

7.  Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.

Authors:  Severin Kengne-Wafo; Laura Massella; Francesca Diomedi-Camassei; Alessandra Gianviti; Marina Vivarelli; Marcella Greco; Gilda Rita Stringini; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 8.237

8.  Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies.

Authors:  M J Mihatsch; T Antonovych; S O Bohman; R Habib; U Helmchen; L H Noel; S Olsen; R K Sibley; E Kemény; G Feutren
Journal:  Clin Nephrol       Date:  1994-01       Impact factor: 0.975

9.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Authors:  Christian Faul; Mary Donnelly; Sandra Merscher-Gomez; Yoon Hee Chang; Stefan Franz; Jacqueline Delfgaauw; Jer-Ming Chang; Hoon Young Choi; Kirk N Campbell; Kwanghee Kim; Jochen Reiser; Peter Mundel
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

10.  Hypoxia decreases podocyte expression of slit diaphragm proteins.

Authors:  Hong Lu; Gaurav Kapur; Tej K Mattoo; William D Lyman
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-07-18
View more
  1 in total

1.  Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease.

Authors:  Jessica Camacho; Alberto Rábano; Paula Marazuela; Anna Bonaterra-Pastra; Garazi Serna; Teresa Moliné; Santiago Ramón Y Cajal; Elena Martínez-Sáez; Mar Hernández-Guillamon
Journal:  Brain Pathol       Date:  2021-09-12       Impact factor: 6.508

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.